However, this program requires that the patient have some form of commercial insurance coverage, meaning it does not help patients whose plans dropped GLP-1 coverage entirely
Plateaus are a sign that your body needs a new approach, not that youve failed
[1] Furthermore, the dose escalation schedule for Wegovystarting at 0.25 mg weekly and gradually increasing to the maintenance dose of 2.4 mgis designed to improve tolerability, but each dose increase can temporarily intensify side effects, as noted in the SmPC
Step 8: Plan your transition
[12] [13] SGLT2 inhibitors have demonstrated robust reductions in hospitalisation for heart failure across risk groups, with cardiovascular death benefits most clearly established in heart failure trials
Weight loss drugs known as GLP-1 receptor agonists are sometimes referred to as miracle drugs, not only because they help people lose weight, but because theyve also been shown to help with many other chronic diseases